Central nervous system effects from a peripherally acting cholinesterase inhibiting agent: interaction with stress or genetics.
Beck
K D
KD
Neurobehavioral Unit, Veterans Affairs New Jersey Health Care System, East Orange 07018, USA.
Zhu
G
G
Beldowicz
D
D
Brennan
F X
FX
Ottenweller
J E
JE
Moldow
R L
RL
Servatius
R J
RJ
D000109:Acetylcholine / Q000378:metabolism*; D000110:Acetylcholinesterase / Q000187:drug effects; D000818:Animals; D001479:Basal Ganglia / Q000187:drug effects / Q000201:enzymology; D001522:Behavior, Animal / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects*; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000633:toxicity*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance / Q000235:genetics; D004597:Electroshock; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D009119:Muscle Contraction / Q000187:drug effects; D009419:Nerve Tissue Proteins / Q000037:antagonists & inhibitors; D018923:Persian Gulf Syndrome / Q000139:chemically induced / Q000503:physiopathology; D016548:Prosencephalon / Q000187:drug effects / Q000201:enzymology; D011729:Pyridostigmine Bromide / Q000009:adverse effects / Q000494:pharmacology / Q000633:toxicity*; D051381:Rats; D011921:Rats, Inbred WKY; D017207:Rats, Sprague-Dawley; D012472:Salivation / Q000187:drug effects; D013312:Stress, Physiological / Q000235:genetics / Q000378:metabolism*
D002800:Cholinesterase Inhibitors; D009419:Nerve Tissue Proteins; D000110:Acetylcholinesterase; D011729:Pyridostigmine Bromide; D000109:Acetylcholine